Skip to content

Walgreens adds EnvisionRx’s Rx90 drug plan

Walgreens and EnvisionRx are launching a new prescription drug program called Rx90 that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications.

Table of Contents

DEERFIELD, Ill. — Walgreens and EnvisionRx are launching a new prescription drug program called Rx90 that is designed to give patients with chronic conditions more flexibility in getting their maintenance medications.

Walgreens Rx window_vert

The program allows patients to fill 90-day prescriptions at any of the nearly 8,200 Walgreens pharmacies nationwide, for the same price they would pay for home delivery of the medications via EnvisionPharmacies’ mail service.

EnvisionRx, a pharmacy benefit management company, is part of Rite Aid Corp.’s wholly owned EnvisionRxOptions division. Rx90 prescriptions can also be filled at Rite Aid’s nearly 4,600 pharmacies, giving the Rx90 the largest 90-day retail prescription medication network in the country, according to EnvisionRx.

In addition to retail access to their maintenance drugs, Rx90 also offers patients integrated care and clinical support from EnvisionRx and Walgreens pharmacists, and targeted, disease specific communications. The support is meant to help change patient behaviors and improve medication adherence, the companies say.

EnvisionRx also says it is able to use client-specific data and its own research to provide health plans and employers with recommendations on customizing their benefit design, communications and clinical strategies to meet their individual needs. Rx90 also promises to help plan sponsors better control drug spend and reduce costly medical expenses associated with increased visits to physicians and emergency rooms, as well with as extended hospitalizations.

“We’re pleased to work with EnvisionRx to create a pharmacy solution that can benefit patients, health plans and employers, and reflects our commitment to provide greater care and service to our customers and patients,” said Alex Gourlay, co-chief operating officer, Walgreens Boots Alliance. “Stronger collaboration with PBMs and health plans is critical in today’s healthcare environment, to help ensure our patients can continue to get the medications they need at prices they can afford, and with the pharmacy support they depend upon.”

By providing consumers with improved pricing, more convenient options on how to fill their 90-day maintenance medications, and the support they need, EnvisionRx and Walgreens say they are working together, as well as with plan sponsors, to address rising healthcare costs.

“In today’s market, plan sponsors need a partner that can truly provide transparency around performance and provide more options for their business and their members,” said Frank Sheehy, chief executive officer of EnvisionRxOptions. “Through Rx90, plan sponsors are able to design the prescription drug benefit plan that’s right for them. Coupled with our proprietary technology platform, we can provide better visibility on results and make adjustments faster than other PBM’s, which helps Envision deliver real value.”

Comments

Latest